The effects of adriamycin and daunomycin on antitumoral immune effector mechanisms in an allogeneic system
- 1 May 1976
- journal article
- research article
- Published by Elsevier in European Journal of Cancer (1965)
- Vol. 12 (5), 371-379
- https://doi.org/10.1016/0014-2964(76)90175-4
Abstract
No abstract availableThis publication has 18 references indexed in Scilit:
- Allogeneic tumor enhancement by levamisole, a new immunostimulatory compound: Studies on cell-mediated immunity and humoral antibody responseEuropean Journal of Cancer (1965), 1975
- AdriamycinAnnals of Internal Medicine, 1974
- SOME CHARACTERISTICS OF THE ANTIBODY-INDUCED CELL-MEDIATED CYTOTOXICITY AGAINST LEUKEMIA CELLSTransplantation, 1974
- Cell-Mediated Cytotoxicity, Allograft Rejection, and Tumor ImmunityAdvances in Immunology, 1974
- Increase of lymphocyte-mediated tumor-cell destruction by certain patient seraInternational Journal of Cancer, 1973
- CYTOTOXIC POTENTIAL OF MOUSE SPLEEN CELLS ON H-2 ANTIBODY-TREATED TARGET CELLSThe Journal of Experimental Medicine, 1973
- SYNERGISTIC OR ANTAGONISTIC EFFECT OF DIFFERENT ANTIBODY CONCENTRATIONS ON IN VITRO LYMPHOCYTE CYTOTOXICITY IN THE MOLONEY SARCOMA VIRUS SYSTEMThe Journal of Experimental Medicine, 1972
- Clinical trials with adriamycinCancer, 1971
- Therapeutic effect and toxicity of adriamycin in patients with neoplastic diseaseCancer, 1971
- ABSORPTION OF GUINEA PIG SERUM WITH AGARTransplantation, 1970